产前糖皮质激素、硫酸镁与早产小于胎龄儿的分娩方式
本文综述了产前糖皮质激素、产时硫酸镁及分娩方式在早产小于胎龄儿中的现有证据;指出针对 threatened preterm birth 的标准干预在小于胎龄儿中的获益可能不必然转化,临床试验或回顾性研究结果不一致或未纳入该亚组,实验模型提示潜在有害效应但临床数据未证实,并讨论了定义异质性、纳入标准差异和糖皮质激素方案对结果不一致的影响及现有文献的知识空白。
要点
- 小于胎龄儿对慢性宫内缺氧和营养缺乏发生生理代谢适应,可能影响产前干预的效应。
- 产前糖皮质激素和硫酸镁在小于胎龄儿中的临床试验或回顾性研究结果不一致或未纳入该亚组。
- 实验模型提示产前糖皮质激素和硫酸镁对小于胎龄儿有潜在有害效应,但临床数据未证实。
核心结论
- 小于胎龄儿早产管理的围产期干预和分娩方式仍为未解决的困境,标准干预的获益可能不必然转化至该亚组。
研究设计与样本
- 本文为综述,讨论小于胎龄儿对宫内异常环境的生理适应、产前糖皮质激素和产时硫酸镁的影响、分娩方式文献及知识空白。
主要发现
- 关于产前糖皮质激素和硫酸镁神经保护的临床试验或回顾性研究在小于胎龄儿中结果不一致,或未纳入该亚组。
- 实验模型提示产前糖皮质激素和硫酸镁在小于胎龄儿中可能有潜在有害效应,但临床数据未证实这些担忧。
- 小于胎龄儿定义的异质性、纳入标准差异和糖皮质激素方案导致结果不一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 小于胎龄儿定义存在异质性。
- 纳入标准存在差异。
- 糖皮质激素方案存在差异。
- 现有文献存在知识空白。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A diagnosis of fetal growth restriction and subsequent preterm birth is associated with increased risks of adverse perinatal and neurodevelopmental outcomes and potentially long-lasting effects to adulthood. Most such cases are associated with placental insufficiency and the fetal response to chronic intrauterine hypoxemia and nutrient deprivation leads to substantial physiological and metabolic adaptations. The management of such pregnancies, especially with respect to perinatal interventions and birth mode, remains an unresolved dilemma. The benefits from standard interventions for threatened preterm birth may not be necessarily translated to pregnancies with small-for-gestational-age fetuses. Clinical trials or retrospective studies on outcomes following administration of antenatal glucocorticoids and magnesium sulfate for neuroprotection when preterm birth is imminent either have yielded conflicting results for small-for-gestational-age fetuses, or did not include this subgroup of patients. Experimental models highlight potential harmful effects of administration of antenatal glucocorticoids and magnesium sulfate in the pregnancies with fetal small for gestational age although clinical data do not substantiate these concerns. In addition, heterogeneity in definitions of fetal small for gestational age, variations in the inclusion criteria, and the glucocorticoid regime contribute to inconsistent results. In this review, we discuss the physiologic adaptions of the small-for-gestational-age fetus to its abnormal in utero environment in relation to antenatal glucocorticoids; the impact of antenatal glucocorticoids and intrapartum magnesium sulfate in pregnancies with fetal small for gestational age; the current literature on birth mode for pregnancies with fetal small for gestational age; and the knowledge gaps in the existing literature.
引用
- Ting JY, Kingdom JC, Shah PS, et al. Antenatal glucocorticoids, magnesium sulfate, and mode of birth in preterm fetal small for gestational age. Am J Obstet Gynecol. 2018. PMID: 29422213. doi:10.1016/j.ajog.2017.12.227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。